| Title |
Clinical Pharmacokinetics and Pharmacodynamics of Immune Checkpoint Inhibitors
|
|---|---|
| Published in |
Clinical Pharmacokinetics, February 2019
|
| DOI | 10.1007/s40262-019-00748-2 |
| Pubmed ID | |
| Authors |
Maddalena Centanni, Dirk Jan A. R. Moes, Iñaki F. Trocóniz, Joseph Ciccolini, J. G. Coen van Hasselt |
X Demographics
The data shown below were collected from the profiles of 43 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 12 | 28% |
| Japan | 2 | 5% |
| United States | 2 | 5% |
| Colombia | 1 | 2% |
| Russia | 1 | 2% |
| Portugal | 1 | 2% |
| Guatemala | 1 | 2% |
| Sweden | 1 | 2% |
| El Salvador | 1 | 2% |
| Other | 1 | 2% |
| Unknown | 20 | 47% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 28 | 65% |
| Practitioners (doctors, other healthcare professionals) | 11 | 26% |
| Scientists | 3 | 7% |
| Science communicators (journalists, bloggers, editors) | 1 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 225 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 225 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 36 | 16% |
| Student > Ph. D. Student | 21 | 9% |
| Student > Bachelor | 20 | 9% |
| Other | 19 | 8% |
| Student > Master | 18 | 8% |
| Other | 30 | 13% |
| Unknown | 81 | 36% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 38 | 17% |
| Pharmacology, Toxicology and Pharmaceutical Science | 33 | 15% |
| Biochemistry, Genetics and Molecular Biology | 23 | 10% |
| Agricultural and Biological Sciences | 7 | 3% |
| Immunology and Microbiology | 6 | 3% |
| Other | 33 | 15% |
| Unknown | 85 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 31. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 February 2024.
All research outputs
#1,283,475
of 25,508,813 outputs
Outputs from Clinical Pharmacokinetics
#37
of 1,606 outputs
Outputs of similar age
#30,024
of 367,844 outputs
Outputs of similar age from Clinical Pharmacokinetics
#3
of 20 outputs
Altmetric has tracked 25,508,813 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,606 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.1. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 367,844 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.